ACC: Semaglutide Beneficial in Obesity-Related Heart Failure, Type 2 Diabetes
Larger reductions seen in heart failure-related symptoms and physical limitations for patients with HFpEF, type 2 diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.